AI Liability in Healthcare: Who’s Responsible? With: Dr. Colleen Lyons
Dr. Colleen Lyons, Trust and Change Ambassador at the FDA, explores the unresolved issue of AI liability in healthcare. She explains that while clinicians remain legally responsible for patient care, questions arise when AI tools influence decisions. Liability could extend to manufacturers, healthcare institutions, or even insurers depending on who vetted, deployed, or profited from the tool. Lyons compares the complexity to global supply chains, where corporations are accountable for ethical behavior across networks of suppliers. She argues that healthcare leaders must embed patient-centric values, train staff to recognize AI limitations, and establish 'sturdy leadership' frameworks. Ultimately, she emphasizes that organizations must prepare for both accountability and intelligent failure, ensuring clinicians have support when AI tools misfire.
Episode Contents:
About the Guest
Dr. Colleen Lyons is an ethics and AI governance expert serving as Trust and Change Ambassador at the FDA. She focuses on liability, organizational change, and embedding values to ensure responsible AI adoption in healthcare.
Key Takeaways
- Clinicians remain legally responsible, but liability could extend to manufacturers and institutions
- AI liability resembles supply chain accountability, requiring oversight across all actors
- Sturdy leadership ensures organizations embed ethics, training, and patient focus
Transcript Summary
Where does AI liability lie in healthcare?
Clinicians are responsible, but institutions and manufacturers may share liability depending on oversight and profit.
How should healthcare organizations prepare for AI?
Embed patient-centric values, train staff to recognize AI limits, and foster sturdy leadership.
What does sturdy leadership mean?
Supporting clinicians, planning for intelligent failure, and balancing ethics with profitability.
More Topics
- AI in Patient Care
- AI in the Healthcare Industry
- AI and Medical Innovation
- Healthcare Ethics and Policy
Keep Exploring
About the Series
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine.
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine.
Mika Newton is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and is no stranger to bringing transformative technologies to market and fostering innovation.